Insider transactions

EDGAR

TELA Bio, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-15.

Open-market purchases (code P)
7 transactions, 3,781,500 shares
Sum of shares × price per share: 4,186,455.75
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–9 of 9

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-15 Filed 2026-10-19Capper Joseph H Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)19,8011.01
19,999.01

Derived: shares × price per share. Exact value 19999.01.

199,628Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested.
Open filing 0001456817-26-000017 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Plovanic William J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)16,0891.01
16,249.89

Derived: shares × price per share. Exact value 16249.89.

60,619Direct (D) No
F1
  • F1 Represents shares of common stock issued in lieu of cash compensation under the Issuer's Amended and Restated Non-Employee Director Compensation Policy. All shares are fully vested.
Open filing 0001685640-26-000006 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-18Capper Joseph H Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)25,0001.2212
30,530

Derived: shares × price per share. Exact value 30530.0000.

179,827Direct (D) No
F2
  • F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.19 to $1.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001456817-26-000015 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-18Capper Joseph H Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)50,0001.1653
58,265

Derived: shares × price per share. Exact value 58265.0000.

154,827Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.14 to $1.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001456817-26-000015 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-16Capper Joseph H Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)50,0001.0588
52,940

Derived: shares × price per share. Exact value 52940.0000.

104,827Direct (D) No
F2
  • F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.01 to $1.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001456817-26-000013 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-09-16Capper Joseph H Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)25,0001.0201
25,502.5

Derived: shares × price per share. Exact value 25502.5000.

54,827Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9899 to $1.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001456817-26-000013 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Getz Heather C Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)12,5000.6649
8,311.25

Derived: shares × price per share. Exact value 8311.2500.

532,500Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6504 to $0.6749. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001481485-26-000008 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-17Getz Heather C Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)15,0000.6978
10,467

Derived: shares × price per share. Exact value 10467.0000.

520,000Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.697 to $0.6994. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001481485-26-000006 Read from the filing’s XML Dispute this row
2025-11-17 Filed 2025-11-17EW HEALTHCARE PARTNERS FUND 2, L.P. 10% owner · Other: See RemarksEW HEALTHCARE PARTNERS FUND 2-A, L.P. 10% owner · Other: See RemarksEW Healthcare Partners Fund 2 GP, L.P. 10% owner · Other: See RemarksEW Healthcare Partners Fund 2-UGP, LLC 10% owner · Other: See Remarks
P

Open market or private purchase of non-derivative or derivative security

Common Stock, par value $0.001 per share
Acquired (A)3,604,0001.11
4,000,440

Derived: shares × price per share. Exact value 4000440.00.

7,714,709Direct (D) No
F1
  • F1 Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P.
Open filing 0000908834-25-000358 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 6,203 filings read, the latest filed 2026-11-12. Prior quarter ending 2026-06-30: 3,765 filings read.

Showing 1–28 of 28

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Essex Woodlands Management, Inc. 7,714,709 SH8,871,915 dollarsNot in the prior quarter’s filings read Open filing 0000908834-26-000507 Filed 2026-11-06 Dispute this row
SILVERARC CAPITAL MANAGEMENT, LLC 2,137,201 SH2,457,781 dollarsUnchanged Prior quarter: 2,137,201Open filing 0001420506-26-002577 Filed 2026-11-12 Dispute this row
PERKINS CAPITAL MANAGEMENT INC 2,082,391 SH2,394,750 dollarsNot in the prior quarter’s filings read Open filing 0000884300-26-000005 Filed 2026-11-02 Dispute this row
UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC Partly reported under another manager641,556 SH537,496 dollarsNot in the prior quarter’s filings read Open filing 0002011649-26-000005 Filed 2026-11-12 Dispute this row
WealthTrust Axiom LLC 550,128 SH632,646 dollarsHigher by 92,394 Prior quarter: 457,734Open filing 0001425949-26-000010 Filed 2026-11-10 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager412,662 SH474,617 dollarsHigher by 23,439 Prior quarter: 389,223Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
WHITE PINE CAPITAL LLC 405,664 SH466,514 dollarsNot in the prior quarter’s filings read Open filing 0001137429-26-000005 Filed 2026-11-09 Dispute this row
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. Partly reported under another manager307,645 SH353,792 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-007537 Filed 2026-11-10 Dispute this row
Wavvest Wealth LLC Partly reported under another manager83,524 SH96,053 dollarsNot in the prior quarter’s filings read Open filing 0002153571-26-000002 Filed 2026-10-21 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager81,737 SH93,997 dollarsHigher by 32,492 Prior quarter: 49,245Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager67,700 SH77,855 dollarsUnchanged Prior quarter: 67,700Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
STATE STREET CORP Partly reported under another manager63,383 SH72,890 dollarsUnchanged Prior quarter: 63,383Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
PNC Financial Services Group, Inc. Partly reported under another manager53,612 SH61,654 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-450808 Filed 2026-11-06 Dispute this row
Destiny Wealth Partners, LLC 52,500 SH41,963 dollarsNot in the prior quarter’s filings read Open filing 0001844369-26-000007 Filed 2026-11-05 Dispute this row
StoneX Group Inc. Partly reported under another manager30,000 SH22,140 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
Rollins Financial Advisors, LLC 28,735 SH33,045 dollarsNot in the prior quarter’s filings read Open filing 0001765380-26-000462 Filed 2026-11-10 Dispute this row
GREAT VALLEY ADVISOR GROUP, INC. 23,602 SH27,142 dollarsNot in the prior quarter’s filings read Open filing 0001769897-26-000005 Filed 2026-11-09 Dispute this row
TD Waterhouse Canada Inc. Partly reported under another manager23,000 SH28,520 dollarsNot in the prior quarter’s filings read Open filing 0002052595-26-000100 Filed 2026-10-16 Dispute this row
PRIMORIS WEALTH ADVISORS, LLC 20,300 SH23,345 dollarsNot in the prior quarter’s filings read Open filing 0002085853-26-001312 Filed 2026-10-28 Dispute this row
J.W. COLE ADVISORS, INC. 16,250 SH18,688 dollarsNot in the prior quarter’s filings read Open filing 0001404763-26-000006 Filed 2026-11-05 Dispute this row
UBS Group AG Partly reported under another manager15,756 SH18,119 dollarsLower by 17,710 Prior quarter: 33,466Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
HighTower Advisors, LLC 11,200 SH12,880 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000933 Filed 2026-11-10 Dispute this row
CITIGROUP INC Partly reported under another manager3,039 SH3,495 dollarsNot in the prior quarter’s filings read Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1,089 SH1,350 dollarsHigher by 1,050 Prior quarter: 39Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
SIMPLEX TRADING, LLC 644 SH740 dollarsLower by 632 Prior quarter: 1,276Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
SBI Securities Co., Ltd. 301 SH346 dollarsNot in the prior quarter’s filings read Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager210 SH242 dollarsUnchanged Prior quarter: 210Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
BARCLAYS PLC Partly reported under another manager6 SH7 dollarsLower by 202 Prior quarter: 208Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Nantahala Capital Management, LLC 11,788,228 SH
  • Stonepine Capital Management, LLC 2,662,427 SH
  • VANGUARD CAPITAL MANAGEMENT LLC 1,568,218 SH
  • DAFNA Capital Management LLC 1,441,029 SH
  • Sio Capital Management, LLC 636,300 SH
  • VANGUARD FIDUCIARY TRUST CO 213,138 SH
  • NORTHERN TRUST CORP 74,790 SH
  • RENAISSANCE TECHNOLOGIES LLC 58,100 SH
  • XTX Topco Ltd 29,558 SH
  • Atom Investors LP 15,473 SH
  • MERCER GLOBAL ADVISORS INC /ADV 14,828 SH
  • Tower Research Capital LLC (TRC) 13,612 SH
  • GOLDMAN SACHS GROUP INC 10,383 SH
  • Vanguard Global Advisers, LLC 4,604 SH
  • WELLS FARGO COMPANY/MN 4,200 SH
  • Steward Partners Investment Advisory, LLC 1,991 SH
  • SIMPLEX TRADING, LLC 1,200 SH
  • OSAIC HOLDINGS, INC. 100 SH
  • ROYAL BANK OF CANADA 59 SH
  • MORGAN STANLEY 37 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
SilverArc Capital Management, LLC Class A Common Stock4.82,137,201.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-096813 Dispute this row
Devesh Gandhi Class A Common Stock4.82,137,201.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-096813 Dispute this row
Nantahala Capital Management, LLC Common Stock, $0.001 par value per share12.945,794,114.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-097280 Dispute this row
Wilmot B. Harkey Common Stock, $0.001 par value per share12.945,794,114.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-097280 Dispute this row
Daniel Mack Common Stock, $0.001 par value per share12.945,794,114.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-097280 Dispute this row
SilverArc Capital Management, LLC Class A Common Stock4.82,137,201.0006/30/2026 Filed 2026-08-11SCHEDULE 13GOpen filing 0001104659-26-093857 Dispute this row
Devesh Gandhi Class A Common Stock4.82,137,201.0006/30/2026 Filed 2026-08-11SCHEDULE 13GOpen filing 0001104659-26-093857 Dispute this row
EW HEALTHCARE PARTNERS FUND 2, L.P. Common Stock, par value $0.001 per share6.773,031,61706/09/2026 Filed 2026-06-09SCHEDULE 13DOpen filing 0001193125-26-264406 Dispute this row
EW HEALTHCARE PARTNERS FUND 2-A, L.P. Common Stock, par value $0.001 per share10.464,683,09206/09/2026 Filed 2026-06-09SCHEDULE 13DOpen filing 0001193125-26-264406 Dispute this row
EW Healthcare Partners Fund 2-GP, L.P. Common Stock, par value $0.001 per share17.237,714,70906/09/2026 Filed 2026-06-09SCHEDULE 13DOpen filing 0001193125-26-264406 Dispute this row
EW Healthcare Partners Fund 2-UGP, LLC Common Stock, par value $0.001 per share17.237,714,70906/09/2026 Filed 2026-06-09SCHEDULE 13DOpen filing 0001193125-26-264406 Dispute this row
Lytton, Laurence W. Common Stock5.52,442,341.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 4Open filing 0000935836-26-000257 Dispute this row
EW HEALTHCARE PARTNERS FUND 2, L.P. Common Stock, par value $0.001 per share6.813,031,61711/17/2025 Filed 2025-11-17SCHEDULE 13G/AAmendment 2Open filing 0000908834-25-000359 Dispute this row
EW HEALTHCARE PARTNERS FUND 2-A, L.P. Common Stock, par value $0.001 per share10.524,683,09211/17/2025 Filed 2025-11-17SCHEDULE 13G/AAmendment 2Open filing 0000908834-25-000359 Dispute this row
EW Healthcare Partners Fund 2 GP, L.P. Common Stock, par value $0.001 per share17.327,714,70911/17/2025 Filed 2025-11-17SCHEDULE 13G/AAmendment 2Open filing 0000908834-25-000359 Dispute this row
EW Healthcare Partners Fund 2-UGP, LLC Common Stock, par value $0.001 per share17.327,714,70911/17/2025 Filed 2025-11-17SCHEDULE 13G/AAmendment 2Open filing 0000908834-25-000359 Dispute this row
Lytton, Laurence W. Common Stock7.22,865,305.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 3Open filing 0000935836-25-000689 Dispute this row
GROW FUNDS, LLC. common shares——09/30/2025 Filed 2025-10-15SCHEDULE 13G/AAmendment 1Open filing 0002032300-25-000002 Dispute this row
Lytton, Laurence W. Common Stock8.53,424,191.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0000935836-25-000529 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

1,805,458 filings read, dated 2004-06-14 to 2026-11-12: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
202484,357
2025235,518
202668,836

Filings made before the SEC required XML are listed, not extracted.

Back to TELA Bio, Inc.